Warrants program oversubscribed

A resolution was passed at Vitrolife’s Extraordinary General Meeting on August 24, 2005 concerning warrants programs for Vitrolife employees and for the members of the Board of Vitrolife AB (publ). The program directed at the employees was over-subscribed by approx. 30 percent. The warrants were thus allocated in proportion to the number subscribed for. The warrants program for the members of the Board of Vitrolife AB (publ) was fully subscribed. “It is gratifying to see that our personnel feel such great confidence in and such commitment to the company,” says Magnus Nilsson, Vitrolife’s CEO. “After some tough years there is great self-confidence concerning both what we have achieved so far and our future opportunities.”

The warrants program for the employees comprised a total of 490,000 separable warrants to subscribe for new shares, where each warrant gives the right to subscribe for one new share (each with a nominal value of SEK 1.0) in the company. Subscription for shares in accordance with the conditions for the warrants may take place during the period as from September 3, 2007 up until September 3, 2008. The subscription price amounts to SEK 30.90. The warrants program for the members of the Board of Vitrolife AB (publ), excluding the Chairman of the Board and the proposer Skanditek’s CEO Patrik Tigerschiöld, comprised a total of 60,000 warrants. The conditions were otherwise the same as for the warrants program for the employees. The full conditions for the program are available on the company’s home page , www.vitrolife.com. September 13, 2005 Kungsbacka, Sweden Magnus Nilsson CEO Questions should be addressed to: Magnus Nilsson, CEO, phone +46 31 721 80 00 or +46 708 22 80 61. Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.